T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab
Research output: Contribution to journal › Journal article › Research › peer-review
T cells influence outcome in follicular lymphoma, but their contributions seem to be modified by therapy. Their impact in patients receiving rituximab without chemotherapy is unknown.
Original language | English |
---|---|
Journal | Clinical Cancer Research |
Volume | 17 |
Issue number | 12 |
Pages (from-to) | 4136-44 |
Number of pages | 9 |
ISSN | 1078-0432 |
DOIs | |
Publication status | Published - 2011 |
ID: 40153567